| Product Name | MF | CAS | Details |
|---|
| SSTR4 agonist 2 | C18H24N4O | 1638589-52-2 | Details |
| CD73-IN-7 | C13H11ClN4O2 | 2763709-14-2 | Details |
| SN40 | C18H20N2O2 | 2768663-14-3 | Details |
| CXCR4 antagonist 7 | C15H17N5O3 | 1185451-72-2 | Details |
| As-358 | C18H31NO2 | 2222042-47-7 | Details |
| PFM03 | C14H15NO2S2 | 1558598-48-3 | Details |
| B-Raf IN 8 | C18H17N3O2 | 1215313-19-1 | Details |
| Vin-C01 | C20H24N2O | 23173-26-4 | Details |
| MNK1/2-IN-5 | C17H16N4O2 | 1426928-20-2 | Details |
| OYYF-175 | C17H14FN5 | 65829-22-3 | Details |
| NLRP3 antagonist 1 | C16H18N6O | 2454017-83-3 | Details |
| LY3143921 | C16H12FN5O | 1627696-52-9 | Details |
| PCAF-IN-1 | C15H11ClN6 | 2439194-86-0 | Details |
| OX01914 | C17H14N4O | 49676-35-9 | Details |
| gp120-IN-2 | C15H18N2O5 | 123629-42-5 | Details |
| F8-S43-S3 | C12H10N4O3S | 1632320-78-5 | Details |
| Xanthine oxidase-IN-4 | C15H13N5O2 | 2642137-96-8 | Details |
| AAK1-IN-2 | C20H20N4 | 1802703-21-4 | Details |
| STAT3-IN-10 | C17H13NO5 | 2499491-04-0 | Details |
| Enpp-1-IN-10 | C13H12N6OS | 2631704-38-4 | Details |
| AChE/BChE-IN-3 | C15H24N2O3 | 2410992-65-1 | Details |
| Antitubercular agent-28 | C17H14N4O2 | 2460651-10-7 | Details |
| AY1511 | C17H14O6 | 2559709-99-6 | Details |
| M1 ligand 1 | C20H21NO2 | 2479356-53-9 | Details |
| SN05 | C18H17NO4 | 2768663-51-8 | Details |
| EGFR-IN-67 | C18H17N3S | 2416924-99-5 | Details |
| Influenza virus-IN-2 | C17H17NO5 | 2411584-06-8 | Details |
| Cdc7-IN-12 | C16H14N2O2S | 2764865-33-8 | Details |
| Tegafur-Uracil | C12H13FN4O5 | 74578-38-4 | Details |
| R110 | C15H17ClN2OS | 1985622-33-0 | Details |
| Cdc7-IN-17 | C13H15N5OS | 2253686-94-9 | Details |
| Antibacterial agent 114 | C19H14N4O | 2733391-71-2 | Details |
| FabH-IN-1 | C17H16N2OS | 2692652-49-4 | Details |
| PCSK9 modulator-3 | C16H9F2N3O | 2476490-18-1 | Details |
| S-(N-PhenethylthiocarbaMoyl)-L-cysteine | C12H16N2O2S2 | 53330-02-2 | Details |
| HPV18-IN-1 | C14H10N4OS | 331851-78-6 | Details |
| Dyrk1A-IN-3 | C18H16N6 | 2493976-27-3 | Details |
| MAPK-IN-1 | C19H18O4 | 2470587-69-8 | Details |
| COX/5-LOX-IN-1 | C18H30O3 | 2468802-82-4 | Details |
| BB 0305179 | C21H29NO | 2512200-83-6 | Details |
| SLEC-11 | C18H17FN2O | 863761-17-5 | Details |
| Cholesterol 24-hydroxylase-IN-1 | C17H23N5O | 1613480-70-8 | Details |
| Tubulin polymerization-IN-14 | C15H15ClN2O2 | 2417134-05-3 | Details |
| MAO-B-IN-16 | C18H19NO3 | 1021238-13-0 | Details |
| EGFR-IN-53 | C14H13N3O2S | 2418549-33-2 | Details |
| NSC81111 | C19H16O4 | 1678-14-4 | Details |
| isoCA-4 | C18H20O5 | 1067880-31-2 | Details |
| Nln activator 1 | C15H15N5O | 2659214-18-1 | Details |
| Influenza virus-IN-1 | C16H17NO5 | 108729-21-1 | Details |
| Anti-inflammatory agent 11 | C14H14N4OS | 63932-07-0 | Details |
| Antibacterial agent 74 | C16H20N2O3 | 1644387-48-3 | Details |
| hCAIX-IN-7 | C18H12FNO3 | 2451479-58-4 | Details |
| A1AR antagonist 2 | C17H12N4O | 1441961-74-5 | Details |
| ZDWX-25 | C17H15N3O3 | 2668297-70-7 | Details |
| CDK1/2/4-IN-1 | C15H16N2O2S | 2414633-49-9 | Details |
| AChE/BChE-IN-4 | C17H26N2O3 | 2294963-47-4 | Details |
| TRAP-6-IN-1 | C18H20O3 | 2068737-10-8 | Details |
| T761-0184 | C16H20FN3O | 1340907-57-4 | Details |
| NMDA receptor modulator 3 | C12H9F3N2O2S | 2758256-02-7 | Details |
| hMAO-B-IN-2 | C18H23NO3 | 2454459-87-9 | Details |
| SIRT1-IN-3 | C13H15BrN2O | 2470969-91-4 | Details |
| Carboxylesterase-IN-3 | 2764748-92-5 | Details |
| ZC0101 | C17H15N3O2 | 2541604-52-6 | Details |
| A2AAR antagonist 1 | C12H8BrN3O | 1784491-64-0 | Details |
| Aldose reductase-IN-4 | C14H10FNO3S | 2446136-17-8 | Details |
| MAO-B-IN-15 | C17H18FNO2 | 2032436-79-4 | Details |
| AAK1-IN-3 | C20H20N4 | 1802703-20-3 | Details |
| Mycobactin-IN-2 | C15H13BrN2O | 421573-09-3 | Details |
| Talaglumetad hydrochloride | C11H17ClN2O5 | 441765-97-5 | Details |
| UCSF678 | C15H18N2O2S | 2361697-55-2 | Details |
| AR antagonist 3 | C15H18N2O3S | 349573-58-6 | Details |
| GABAA receptor agent 8 | C19H16N4O | 2376841-54-0 | Details |
| Cdc7-IN-9 | C15H17N5OS | 2649407-21-4 | Details |
| AChE/BChE/BACE-1-IN-2 | C18H20F2N2 | 1877000-20-8 | Details |
| Anti-inflammatory agent 14 | C16H16N2O2S | 894496-27-6 | Details |
| Tubulin polymerization-IN-36 | C18H18N2O3 | 2011784-91-9 | Details |
| SARS-CoV-2 Mpro-IN-1 | C15H11FN2O2S | 2758359-91-8 | Details |
| Xanthine oxidase-IN-7 | C16H14N4O2 | 2411698-59-2 | Details |
| ZDLD13 | C18H14N4O | 2762278-95-3 | Details |
| NMDA receptor modulator 2 | C13H11F3N2O2 | 2758255-05-7 | Details |
| MAO-B-IN-13 | C18H19NO3 | 2105918-34-9 | Details |
| Vanin-1-IN-2 | C15H12N4OS | 2054952-13-3 | Details |
| LP-284 | C16H20N2O4 | 2412580-47-1 | Details |
| PCSK9 modulator-2 | C17H12F2N2 | 2365416-53-9 | Details |
| PRMT5-IN-10 | C13H17N5O4 | 2567564-23-0 | Details |
| Antileishmanial agent-8 | C18H16O4 | 2477608-96-9 | Details |
| ACA-28 | C17H16O6 | 948044-25-5 | Details |
| FBA-IN-1 | C15H13NOSe | 2605897-57-0 | Details |
| Neuronotoxicity-IN-1 | C17H15N3OS | 190843-45-9 | Details |
| SARS-CoV-2-IN-16 | C17H20N2O2 | 2761911-40-2 | Details |
| A2A/A1 AR antagonist-1 | C15H12N6O2 | 2445615-24-5 | Details |
| PCSK9 modulator-4 | C17H11F2N3O | 2476490-20-5 | Details |
| Antibacterial agent 122 | C15H14N2O3S | 109310-99-8 | Details |
| F8-S40 | C13H11N3O3S | 301347-96-6 | Details |
| Tubulin polymerization-IN-22 | C19H16O4 | 2493052-22-3 | Details |
| Neboglamine hydrochloride | C13H25ClN2O3 | 2759182-59-5 | Details |
| GABAA receptor agent 6 | C18H25N3O2 | 1808463-81-1 | Details |
| β-Lactamase-IN-7 | C16H15N3S2 | 2419903-21-0 | Details |
| Metallo-β-lactamase-IN-4 | C10H14N4O3S2 | 2711044-25-4 | Details |
| A1AR antagonist 6 | C17H15N3O2 | 329693-22-3 | Details |
| Product Total： Product Page： | ||||
| 109 110 111 112 113 114 115 116 117 118 119 120 121 122 123 124 125 126 127 128 129 130 131 132 133 134 135 136 137 138 139 140 141 142 143 144 145 146 147 148 149 150 151 152 153 154 155 156 157 158 159 160 161 162 163 164 165 166 167 168 169 170 171 172 173 174 175 176 177 178 179 180 181 182 183 184 185 186 187 188 189 190 191 192 193 194 195 196 197 198 | ||||